<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: diet drug</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>FDA approves 3 new drugs for type 2 diabetes</title>
   	 <description>(HealthDay)—The U.S. Food and Drug Administration late Friday approved three new medications to help people battle type 2 diabetes.</description>
     <link>http://medicalxpress.com/news/2013-01-fda-drugs-diabetes.html</link>
	 <category>Medications</category>
	 <pubDate>Sat, 26 Jan 2013 07:00:01 EST</pubDate>
	 <guid isPermaLink="false">news278401620</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/fdaapproves3.jpg" width="90" height="90" />
</item>
<item>
     <title>Reverse engineering epilepsy's 'miracle' diet</title>
   	 <description>For decades, neurologists have known that a diet high in fat and extremely low in carbohydrates can reduce epileptic seizures that resist drug therapy. But how the diet worked, and why, was a mystery&amp;#151;so much so that in 2010, The New York Times Magazine called it &quot;Epilepsy's Big, Fat Miracle.&quot;</description>
     <link>http://medicalxpress.com/news/2012-05-reverse-epilepsy-miracle-diet.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Wed, 23 May 2012 12:24:29 EST</pubDate>
	 <guid isPermaLink="false">news256994639</guid>
	 
</item>
<item>
     <title>FDA advisers recommend approving weight loss drug</title>
   	 <description>(AP) --  Advisers to government health regulators on Thursday recommended that that they approve sales of what would be the first new prescription weight-loss drug in the U.S. in more than a decade, despite concerns over cardiac risks.</description>
     <link>http://medicalxpress.com/news/2012-05-fda-weight-loss-drug.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 10 May 2012 18:09:44 EST</pubDate>
	 <guid isPermaLink="false">news255892178</guid>
	 
</item>
<item>
     <title>Study shows ability of new agent to prevent strokes in patients with atrial fibrillation</title>
   	 <description>In the primary result from the largest double-blind study ever completed to assess a drug's effect in the prevention of stroke in patients with atrial fibrillation, a common heart rhythm abnormality, rivaroxaban, an anti-clotting drug, was shown to be an attractive alternative to warfarin, the current standard for treatment of atrial fibrillation.</description>
     <link>http://medicalxpress.com/news/2011-08-heart-patients-benefit-drug.html</link>
	 <category>Cardiology</category>
	 <pubDate>Wed, 10 Aug 2011 17:21:26 EST</pubDate>
	 <guid isPermaLink="false">news232215654</guid>
	 
</item>


</channel>
</rss>
